🇺🇸 FDA
Pipeline program

Jiedu Tongluo granules

XiyuanH

Phase 1 small_molecule completed

Quick answer

Jiedu Tongluo granules for Post-stroke Depression is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Post-stroke Depression
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials